In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 2, 1997, Pages 163-167

  Pujol, Isabel ^a   Guarro, Josep ^b   Gené, Josepa ^b   Sala, Joan ^b  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; DILUTION; FUSARIUM; FUSARIUM OXYSPORUM; FUSARIUM SOLANI; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS;

ANTIFUNGAL AGENTS; FUSARIUM; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0031055866     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.2.163     Document Type: Article

References (23)

1. Guarro, J., de Hoog, G. S., Figueras, M. J. & Gené, J. (1995). Rare opportunistic fungi. In Atlas of Clinical Fungi (de Hoog, G. S. & Guarro, J., Eds), pp. 241-675. Centraalbureau voor Schimmelcultures, Baarn.
2. Anaissie, E., Kantarajan, H., Ro, J., Hopfer, R., Rolston, K., Fainstein, V. et al. (1988). The emerging role of Fusarium infections in patients with cancer. Medicine 67, 77-83.
3. Anaissie, E. J. & Rinaldi, M. G. (1990). Fusarium and the immunocompromised host: liaisons dangereuses. New York State Journal of Medicine 90, 586-7.
4. Nelson, P. E., Dignani, M. C. & Anaissie, E. J. (1994). Taxonomy, biology, and clinical aspects of Fusarium species. Clinical Microbiology Reviews 7, 479-504.
5. Guarro, J. & Gené, J. (1995). Opportunistic fusarial infections in humans. European Journal of Clinical Microbiology & Infectious Diseases 14, 741-54.
6. National Committee for Clinical Laboratory Standards. (1992). Reference Method for Broth Dilution Antifungal Susceptibility Testing for Yeasts: Proposed Standard M27-P. NCCLS, Villanova, PA.
7. Espinel-Ingroff, A., Kerkering, T. M., Goldson, P. R. & Shadomy, S. (1991). Comparison study of broth macrodilution and microdilution antifungal susceptibility tests. Journal of Clinical Microbiology 29, 1089-94.
8. Espinel-Ingroff, A., Kish, C. W., Kerkering, T. M., Fromtling, R. A., Bartizal, K., Galgiani, J. N. et al. (1992). Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. Journal of Clinical Microbiology 30, 3138-45.
9. Barchiesi, F., Colombo, A. L., McGough, D. A. & Rinaldi, M. G. (1994). Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard. Journal of Clinical Microbiology 32, 2494-500.
10. Sewell, D. L., Pfaller, M. A. & Barry, A. L. (1994). Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole. Journal of Clinical Microbiology 32, 2099-102.
11. Espinel-Ingroff, A., Dawson, K., Pfaller, M., Anaissie, E., Breslin, B., Dixon, D. et al. (1995). Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrobial Agents and Chemotherapy 39, 314-9.
12. Pujol, I. Guarro, J. Llop, C. Soler, L. & Fernández-Ballart, J. (1996). Comparison study of broth macrodilution and microdilution antifungal susceptibility tests for the filamentous fungi. Antimicrobial Agents and Chemotherapy 40, 2106-10.
13. Reuben, A., Anaissie, E., Nelson, P. E., Hashem, R., Legrand, C., Ho, D. H. et al. (1989). Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method. Antimicrobial Agents and Chemotherapy 33, 1647-9.
14. Sekhon, A. S., Padhye, A. A., Garg, A. K., Ahmad, H. & Mole- dina, N. (1994). In vitro sensitivity of medically significant Fusarium species to various antimycotics. Chemotherapy 40, 239-44.
15. Rotowa, N. A., Shadomy, H. J. & Shadomy, S. (1990). In vitro activities of polyene and imidazole antifungal agents against unusual opportunistic fungal pathogens. Mycoses 33, 203-11.
16. Sanz, F., Soledad Cuétara, M., del Palacio, A., Campbell, C. K., Johnson, L., Urruzunu, P., et al. (1993). Problemas que plantea el aislamiento en hemocultivo (Bactec NR-860) de hongos miceliales (Fusarium solani). Enfermedades Infecciosas y Microbiologia Clinica 11, 490-3.
17. Nati, R., Dreyfus, F., Lanore, J. J., Brunet, F., Robin, P., Bordier, C., et al. (1988). Localisations cutanées d'une septicémie à Fusarium oxysporum survenant chez un patient en aplasie médullaire. Annales de Dermatologie et de Venéréologie 115, 337-8.
18. Merz, W. G., Karp, J. E., Hoagland, M., Jett-Goheen, M., Junkins, J. M. & Hood, A. F. (1988). Diagnosis and successful treatment of fusariosis in the compromised host. Journal of Infectious Diseases 158, 1046-55.
19. Gamis, A. S., Gudnason, T., Giebink, G. S. & Ramsay, N. K. C. (1991). Disseminated infection with Fusarium in recipients of bone marrow transplants. Reviews of Infectious Diseases 13, 1077-88.
20. Poirot, J. L., Laporte, J. P., Gueho, E., Verny, A., Gorin, N. C., Najman, A. et al. (1985). Mycose profonde à Fusarium. Presse Médicale 14, 2300-1.
21. Melcher, G. P., McGough, D. A., Fothergill, A. W., Norris, C. & Rinaldi, M. G. (1993). Disseminated hyalohyphomycosis caused by a novel human pathogen, Fusarium napiforme. Journal of Clinical Microbiology 31, 1461-7.
22. Barrios, N. J., Kirkpatrick, D., Murciano, A., Stipe, K., Van Dyke, R. B. A. & Humbert, J. R. (1990). Successful treatment of disseminated Fusarium infection in an immunocompromised child. American Journal of Pédiatric Hematology/Oncology 12, 319-24.
23. Raad, I. & Hachem, R. (1995). Treatment of central venous catheter-related fungemia due to Fusarium oxysporum. Clinical Infectious Diseases 20, 709-11.